Nouryon has increased production capacity for dialkyl peroxide at the company’s Ningbo site, China, by 25 percent after completing a major expansion project. The product, branded as Perkadox 14, is essential in the manufacture of many elastomer-based products, ranging from sports goods to industrial wires and cables.
“Demand for Perkadox 14 in Asia and worldwide is on the rise because it has less odor compared to other organic peroxides on the market, which is ideal for consumer products such as athletic shoe soles and yoga mats,” said Markus Majoor, Global Market Segment Lead at Nouryon. “We manufacture a significant share of the dialkyl peroxide that is used in the market today, and through this expansion we are ready to meet growing customer demand and strengthen our leadership position.”
Johan Landfors, Managing Director Polymer Chemistry at Nouryon, added: “Since 2018, we have invested more than €100 million to build organic peroxides production capacity across the globe, and as a global leader we’ll continue to invest in expanding our operations to maintain our world class level of customer service.”
The Ningbo expansion is the latest in a series of investments by Nouryon to better serve and grow with its customers in the polymer market. For example, the company recently completed projects in India, Mexico, and the United States.
Click here for more information about Nouryon’s recent growth projects.
We are a global specialty chemicals leader. Markets worldwide rely on our essential chemistry in the manufacture of everyday products such as paper, plastics, building materials, food, pharmaceuticals, and personal care items. Building on our nearly 400-year history, the dedication of our 10,000 employees, and our shared commitment to business growth, strong financial performance, safety, sustainability, and innovation, we have established a world-class business and built strong partnerships with our customers. We operate in over 80 countries around the world and our portfolio of industry-leading brands includes Eka, Dissolvine, Trigonox, and Berol.